NuGenerex Immuno-Oncology
NuGenerex is a platform biotechnology company focused on harnessing the power of the immune system with a pipeline of products in development using our novel Ii-Key technology.
Immunotherapy Company Fighting Cancer and Infectious Disease
NuGenerex Immuno-Oncology is a platform biotechnology company focused on harnessing the power of the immune system with a pipeline of products in development using our novel Ii-Key technology. We believe to be truly effective, a vaccine must provide protection against acute infection as well as long-lasting immune memory. Ii-Key vaccines activate the cellular T-Cell response and generate antibodies from the humoral response to fight infection and provide long-term immunity. Our amino acid (peptide) based Ii-Key vaccines have been proven safe and effective in hundreds of clinical trial patients.
Immunotherapy of Cancer
Cancer immunotherapy uses a patient’s own immune system rather than toxic chemotherapies to target and eliminate tumors. In the last decade, antibodies, cellular therapies, and immune checkpoint inhibitors have all become standard of care for the treatment of certain cancers. Ii-Key vaccines can work synergistically in combination with these therapies to enhance the immune response and provide long-term protection that may prevent cancer recurrence.
Contact Us
Want to learn more about NuGenerex Immuno-Oncology or have a question about our approach? Use the contact form and let’s start a conversation.